CS/HB 363 Summary

• Creates Florida Statute 627.64194 to regulate health insurance coverage requirements for abuse-deterrent opioid analgesic drugs

• Allows insurers to require prior authorization for abuse-deterrent opioid products only if they impose the same requirement for non-abuse-deterrent opioid products

• Prohibits insurers from requiring patients to use non-abuse-deterrent opioid products before authorizing abuse-deterrent opioid products

• Defines "abuse-deterrent opioid analgesic drug product" as FDA-approved brand or generic opioids with abuse-deterrence labeling claims

• Effective date: January 1, 2017